One group.
Four specialised divisions.
A consistent brand with clearly differentiated services and dedicated points of contact.
Be healthy Be safe Be well
Divisions
Four specialised divisions
Each division has its own team, services and point of contact.
SMO
Site Management Organisation
Explore Bpharma SMOServices
CRO
Clinical Research Organisation
Explore Bpharma CROServices
Regulatory Affairs
Regulatory strategy, licensing & lifecycle
Explore Regulatory AffairsServices
PV
Pharmacovigilance
Explore Bpharma PV
News
News
News and perspectives from across the Bpharma divisions.
ICH E6(R3): Annex 2 on decentralised and pragmatic trials takes effect in January 2027
The updated Good Clinical Practice guideline has applied in the EU since 23 July 2025. Its Annex 2, on decentralised and pragmatic trials and real-world data, follows on 15 January 2027.
CRO · 6 November 2026
EU HTA Regulation: joint clinical assessments are under way
Since 12 January 2025 new cancer medicines and advanced therapies go through a joint EU clinical assessment. Orphan medicines follow in 2028 and the full scope of the Regulation in 2030.
Regulatory Affairs · 3 November 2026
EU Clinical Trials Regulation: the transition to CTIS is complete
Since 31 January 2025 every clinical trial in the EU runs under the Clinical Trials Regulation, with the Clinical Trials Information System as the single entry point.
CRO · 9 October 2024
Let’s connect
Let’s Find the Right Solution Together.
Tell us about your study, product or question and we will put you in touch with the right division.